Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 77, Issue 1, 2007, Pages 58-61

  Zhang, Huijuan ^a   Liu, Xiaomin ^a   Kuang, Hongyu ^a   Yi, Ran ^a   Xing, Houxun ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Gliclazide; Polymorphism; Type 2 diabetes

Indexed keywords

GLICLAZIDE; HEMOGLOBIN A1C; SULFONYLUREA RECEPTOR 1;

ARTICLE; DRUG EFFICACY; EXON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION;

ADULT; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; GLICLAZIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG;

EID: 34247144968     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.10.021     Document Type: Article

References (17)

1. Huopio H., Otonkoski T., Vauhkonen I., Reimann F., Ashcroft F.M., and Laakso M. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet 361 (2003) 301-307
2. Szoke E., and Gerich J.E. Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Compr. Ther. 31 (2005) 106-112
3. Hansen T., Echwald S.M., Hansen L., Moller A.M., Almind K., Clausen J.O., et al. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes 47 (1998) 598-605
4. Rissanen J., Markkanen A., Karkkainen P., Pihlajamaki J., Kekalainen P., Mykkanen L., et al. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care 23 (2000) 70-73
5. Zychma M.J., Gumprecht J., Strojek K., Grzeszczak W., Moczulski D., Trautsolt W., et al. Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects. Med. Sci. Monit. 8 (2002) CR512-15
6. Ashcroft F.M., and Gribble F.M. Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels. J. Diabetes Complicat. 14 (2000) 192-196
7. Krugluger W., Festa A., Shnawa N., Bucher J., Boltz-Nitulescu G., Schernthaner G., et al. A serine/alanine polymorphism in the nucleotide-binding fold-2 of the sulphonylurea receptor-1 (S1369A) is associated with enhanced glucose-induced insulin secretion during pregnancy. J. Inherit. Metab. Dis. 23 (2000) 705-712
8. Lichter J.B., and Kurth J.H. The impact of pharmacogenetics on the future of healthcare. Curr. Opin. Biotechnol. 8 (1997) 692-695
9. Reis A.F., Ye W.Z., Dubois-Laforgue D., Bellanne-Chantelot C., Timsit J., and Velho G. Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians. Hum. Genet. 107 (2000) 138-144
10. Malecki M.T. Genetics of type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 68 (2005) S10-S21
11. Schulze M.B., and Hu F.B. Primary prevention of diabetes: what can be done and how much can be prevented?. Annu. Rev. Public Health 26 (2005) 445-467
12. Daimon M., Ji G., Saitoh T., Oizumi T., Tominaga M., Nakamura T., et al. Large-scale search of SNPs for type 2 DM susceptibility genes in a Japanese population. Biochem. Biophys. Res. Commun. 302 (2003) 751-758
13. Boileau P., Wolfrum C., Shih D.Q., Yang T.A., Wolkoff A.W., and Stoffel M. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3). Diabetes 51 (2002) S343-S348
14. ATP?. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E403-E412
15. Goksel D.L., Fischbach K., Duggirala R., Mitchell B.D., Aguilar-Bryan L., Blangero J., et al. Variant in sulfonylurea receptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR-1 gene variant and hyperinsulinemia. Hum. Genet. 103 (1998) 280-285
16. Aguilar-Bryan L., Nichols C.G., Wechsler S.W., Clement IV J.P., Boyd III A.E., Gonzalez G., et al. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268 (1995) 423-426
17. Chen F.L., Shi W.J., Zhang X.M., Li R.Y., Song H.D., Hu R.M., et al. Correlation between polymorphism of sulfonylurea receptor 1 gene and type 2 diabetes. Chin. J. Endocrinol. Metab. 19 (2003) 371-374